The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

"In the future, the insights gained from this work could lead to the development of much-needed novel ways." Researchers ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

In a leap for urban ecology, researchers have unveiled a cutting-edge method to dynamically estimate seasonal tree heights in ...

"Our findings show that Zika virus isn't just passively transmitted." Scientist reveals disturbing way Zika virus affects humans: 'It actively manipulates human biology to ensure its survival' first ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

BEIJING -- Chinese scientists have developed a gene-editing technique to reduce corn plant height, enabling the creation of ...

Jennison Associates LLC lifted its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the ...

Tax advantages offered by PEA-PME and PEA are only available to French residents. *Shares of European companies with fewer than 5,000 employees and an annual revenue of less than €1.5 billion or total ...